Hemorrhagic fever viruses as biological weapons: medical and public health management.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2002-05-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/JAMA.287.18.2391PMID 11988060
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Experimental Rift Valley fever in rhesus macaques

  2005cited by this paper
• [Tularemia as a biological weapon].

  2002cited by this paper
• Dengue and other emerging flaviviruses.

  2001cited by this paper
• Shortage of vaccines during a yellow fever outbreak in Guinea.

  2001cited by this paper
• Yellow fever: an update.

  2001influential reference
• Botulinum toxin as a biological weapon: medical and public health management.

  2001cited by this paper
• Germs: Biological Weapons and America's Secret War

  2001cited by this paper
• Outbreak of Ebola hemorrhagic fever Uganda, August 2000-January 2001.

  2001cited by this paper
• Tularemia as a biological weapon: medical and public health management.

  2001cited by this paper
• Passive Transfer of Antibodies Protects Immunocompetent and Immunodeficient Mice against Lethal Ebola Virus Infection without Complete Inhibition of Viral Replication

  2001cited by this paper
• [Anthrax as biological weapon].

  2001cited by this paper
• Additive Effect of Neutralizing Antibody and Antiviral Drug Treatment in Preventing Virus Escape and Persistence

  2000cited by this paper
• Plague as Biological Weapon

  2000cited by this paper
• Marburg and Ebola virus infections in laboratory non-human primates: a literature review.

  2000cited by this paper
• Ebola haemorrhagic fever--a review.

  2000cited by this paper
• Rift valley fever.

  2000cited by this paper
• Tickborne Infectious Diseases: Diagnosis and Management

  2000cited by this paper
• Intravenous ribavirin therapy for adenovirus pneumonia

  2000cited by this paper
• Fatal illnesses associated with a new world arenavirus--California, 1999-2000.

  2000cited by this paper
• Hemorrhagic fever virus-induced changes in hemostasis and vascular biology

  2000influential reference
• Development of a preventive vaccine for Ebola virus infection in primates

  2000cited by this paper
• Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

  2000cited by this paper
• Unexpected Ebola virus in a tertiary setting: Clinical and epidemiologic aspects

  2000cited by this paper
• Effective Vaccine for Lassa Fever

  2000cited by this paper
• The Marburg virus outbreak of 1967 and subsequent episodes.

  1999cited by this paper
• Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

  1999cited by this paper
• Human infection due to Ebola virus, subtype Côte d'Ivoire: clinical and biologic presentation.

  1999cited by this paper
• Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World--Told from the Inside by the Man Who Ran It

  1999cited by this paper
• Virus Taxonomy. Seventh Report of the International Committee on Taxomony of Viruses

  1999cited by this paper
• Ebola outbreak in Kikwit, Democratic Republic of the Congo: discovery and control measures.

  1999cited by this paper
• Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure.

  1999cited by this paper
• An analysis of features of pathogenesis in two animal models of Ebola virus infection.

  1999cited by this paper
• The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit.

  1999cited by this paper
• Management of a Sabiá Virus-Infected Patient in a US Hospital

  1999influential reference
• Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients.

  1999cited by this paper
• Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995.

  1999cited by this paper
• Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995.

  1999cited by this paper
• The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis.

  1999cited by this paper
• The Marburg virus outbreak of 1967 and subsequent episodes.

  1999influential reference
• An epizootic of Rift Valley fever in Egypt in 1997.

  1999cited by this paper
• Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee.

  1999cited by this paper
• Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit.

  1999cited by this paper
• Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome.

  1999cited by this paper
• Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience.

  1999cited by this paper
• Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

  1999cited by this paper
• Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit.

  1999cited by this paper
• A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidémies à Kikwit.

  1999cited by this paper
• DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge.

  1998cited by this paper
• Susceptibility of selected strains of Australian mosquitoes (Diptera: Culicidae) to Rift Valley fever virus.

  1998cited by this paper
• Tuberculosis risk in funeral home employees.

  1998cited by this paper
• Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.

  1998cited by this paper
• Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group.

  1998cited by this paper
• The effect of high-efficiency particulate air respirator design on occupational health: a pilot study balancing risks in the real world.

  1997cited by this paper
• Treatment of Bolivian hemorrhagic fever with intravenous ribavirin.

  1997cited by this paper
• The Effect of High-Efficiency Particulate Air Respirator Design on Occupational Health: A Pilot Study Balancing Risks in the Real World

  1997cited by this paper
• Clinical recognition and management of patients exposed to biological warfare agents.

  1997cited by this paper
• Personal respiratory protection against Mycobacterium tuberculosis.

  1997cited by this paper
• Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee.

  1996cited by this paper
• Perspectives in fatal epidemics.

  1996cited by this paper
• Patients infected with high-hazard viruses: scientific basis for infection control.

  1996cited by this paper
• Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure.

  1996cited by this paper
• Ebola haemorrhagic fever in Zaire

  1996cited by this paper
• Certain pathogenetic characteristics of a disease in monkeys in infected with the Marburg virus by an airborne route

  1995cited by this paper
• Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus.

  1995cited by this paper
• Update: management of patients with suspected viral hemorrhagic fever--United States.

  1995cited by this paper
• Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory.

  1995cited by this paper
• [Certain pathogenetic characteristics of a disease in monkeys in infected with the Marburg virus by an airborne route].

  1995cited by this paper
• Re-emergence of Bolivian hemorrhagic fever.

  1994cited by this paper
• Antiviral treatment of Argentine hemorrhagic fever.

  1994cited by this paper
• Field evaluation of formalin inactivated Kyasanur forest disease virus tissue culture vaccine in three districts of Karnataka state.

  1994cited by this paper
• Clinical study of 100 cases of Kyasanur Forest disease with clinicopathological correlation.

  1993cited by this paper
• Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease.

  1993cited by this paper
• Combined simian hemorrhagic fever and Ebola virus infection in cynomolgus monkeys.

  1992cited by this paper
• [The effect of the methods for producing an experimental Marburg virus infection on the characteristics of the course of the disease in green monkeys].

  1992cited by this paper
• Aerosol infection of rhesus macaques with Junin virus.

  1992cited by this paper
• Candid No. 1 Argentine hemorrhagic fever vaccine protects against lethal Junin virus challenge in rhesus macaques.

  1992cited by this paper
• The effect of the methods for producing an experimental Marburg virus infection on the characteristics of the course of the disease in green monkeys

  1992cited by this paper
• Clinical aspects of African viral hemorrhagic fevers.

  1989cited by this paper
• Epidemiology of hemorrhagic fever viruses.

  1989cited by this paper
• A plasma inhibitor of platelet aggregation in patients with Argentine hemorrhagic fever.

  1989cited by this paper
• Analytical study of a Rift Valley fever epidemic.

  1989cited by this paper
• Hemostatic derangement produced by Rift Valley fever virus in rhesus monkeys.

  1989cited by this paper
• Clinical, clinicopathologic, and hematologic features of Kyasanur Forest disease.

  1989cited by this paper
• Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug.

  1989cited by this paper
• Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha.

  1989cited by this paper
• Clinical features of Lassa fever in Liberia.

  1989cited by this paper
• Vector potential of selected North American mosquito species for Rift Valley fever virus.

  1988cited by this paper
• A case-control study of the clinical diagnosis and course of Lassa fever.

  1987cited by this paper
• Epidemiologic and clinical features of Crimean-Congo hemorrhagic fever in southern Africa.

  1987cited by this paper
• Effect of ribavirin and tributylribavirin on argentine hemorrhagic fever (Junin virus) in guinea pigs

  1986cited by this paper
• Lassa fever. Effective therapy with ribavirin.

  1986cited by this paper
• Rift Valley fever virus vaccine trial: study of neutralizing antibody response in humans.

  1985cited by this paper
• Importance of dose of neutralising antibodies in treatment of Argentine haemorrhagic fever with immune plasma.

  1984cited by this paper
• Textbook of human virology

  1984cited by this paper
• Biosafety in microbiological and biomedical laboratories

  1984cited by this paper
• Endemic Lassa fever in Liberia. I. Clinical and epidemiological aspects at Curran Lutheran Hospital, Zorzor, Liberia.

  1984cited by this paper
• Guideline for isolation precautions in hospitals

  1984cited by this paper
• Effect of environmental factors on aerosol‐induced lassa virus infection

  1984cited by this paper
• The use of Lassa fever convalescent plasma in Nigeria.

  1984cited by this paper
• Protection against a pathogenic strain of Junin virus by mucosal infection with an attenuated strain.

  1983cited by this paper

• Prolyl tRNA Synthetase Is Required for Mammarenavirus Multiplication.

  2026cites this paper
• Targeting the VP24-Karyopherin-α Interface With Phytocompounds: A Structure-Based Molecular Screening and Dynamic Simulation Approach to Rescue Immune Responses Against Ebola Virus

  2026cites this paper
• Prolyl tRNA Synthetase Is Required for Mammarenavirus Multiplication

  2026cites this paper
• Immune Evasion by the NSs Protein of Rift Valley Fever Virus: A Viral Houdini Act

  2025cites this paper
• Crimean-Congo hemorrhagic fever (CCHF) in a child with petechiae, purpura, fever, and ecchymosis: a case reported and literature review

  2025cites this paper
• Pathogenesis of Chapare virus in cynomolgus macaques

  2025influential citation
• Dynamics of Ebola virus transmission with vaccination control using Caputo-Fabrizio Fractional-order derivative analysis

  2025cites this paper
• From Aerosol to Signal: Advances in Biosensor Technologies for Airborne Biothreat Detection

  2025cites this paper
• Tick Diversity, Emerging Tick-Borne Pathogens, and Public Health Implications Across Africa: A Systematic Review

  2025cites this paper
• Future Trends and Developments in Weapon Selection using the DEMATEL Method

  2025cites this paper
• Interactome profiling reveals the LCMV nucleoprotein co-opts DDX helicases through conserved interfaces.

  2025cites this paper
• A cell-free biosensor for multiplexed and sensitive detection of biological warfare agents.

  2024cites this paper
• Deep mutational scanning reveals functional constraints and antibody-escape potential of Lassa virus glycoprotein complex.

  2024cites this paper
• Plasmid-Based Lassa Virus Reverse Genetics.

  2024cites this paper
• Deep mutational scanning reveals functional constraints and antigenic variability of Lassa virus glycoprotein complex

  2024cites this paper
• A review of emerging health threats from zoonotic New World mammarenaviruses

  2024cites this paper
• Bioinformatic, Biochemical, and Immunological Mining of MHC Class I Restricted T Cell Epitopes for a Marburg Nucleoprotein Microparticle Vaccine

  2024cites this paper
• Design, Synthesis, and Biological Evaluation of Benzimidazole Derivatives as Potential Lassa Virus Inhibitors

  2023cites this paper
• The Biosafety Research Road Map: The Search for Evidence to Support Practices in the Laboratory—Crimean Congo Haemorrhagic Fever Virus and Lassa Virus

  2023cites this paper
• Pathogenesis of aerosolized Ebola virus variant Makona in nonhuman primates.

  2023cites this paper
• Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases

  2023cites this paper
• Potential threats of Marburg virus in the Sub-Saharan African region: bridging the gaps

  2023cites this paper
• TaqMan Multiplex Real-time PCR Assay for Crimean-Congo Hemorrhagic Fever Virus Diagnosis Using Armored RNA Technology

  2023cites this paper
• Rift Valley fever virus outbreak in Mauritania yet again in 2022: No room for complacency

  2023cites this paper
• Understanding Sabiá virus infections (Brazilian mammarenavirus).

  2022cites this paper
• Role of vector in transmission of viral hemorrhagic fever

  2022cites this paper
• Hantavirus Induced Kidney Disease

  2022cites this paper
• Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical Trials

  2022cites this paper
• Interaction of Lassa virus fusion and membrane proximal peptides with late endosomal membranes.

  2022cites this paper
• Peltzman Revisited: Quantifying 21st-Century Opportunity Costs of Food and Drug Administration Regulation

  2022cites this paper
• Lassa virus glycoprotein complex review: insights into its unique fusion machinery

  2022cites this paper
• Bacterium-Like Particles Displaying the Rift Valley Fever Virus Gn Head Protein Induces Efficacious Immune Responses in Immunized Mice

  2022cites this paper
• Visualizing the Knowledge Base and Research Hotspot of Public Health Emergency Management: A Science Mapping Analysis-Based Study

  2022cites this paper
• Taylor Series Expansion Method To Compute Approximate Solution for Nonlinear Dynamical System

  2022cites this paper
• Potential and action mechanism of favipiravir as an antiviral against Junin virus

  2021cites this paper
• Mechanisms of Immune Evasion by Ebola Virus.

  2021cites this paper
• Designing a multi-epitope vaccine against the Lassa virus through reverse vaccinology, subtractive proteomics, and immunoinformatics approaches

  2021cites this paper
• Peltzman Revisited: Quantifying 21st Century Opportunity Costs of FDA Regulation

  2021cites this paper
• Controversies’ clarification regarding ribavirin efficacy in measles and coronaviruses: Comprehensive therapeutic approach strictly tailored to COVID-19 disease stages

  2021cites this paper
• Antibody-Based Inhibition of Pathogenic New World Hemorrhagic Fever Mammarenaviruses by Steric Occlusion of the Human Transferrin Receptor 1 Apical Domain

  2021cites this paper
• Simultaneous tropical disease identification with PZT-5H piezoelectric material including molecular mass biosensor microcantilever collection

  2021cites this paper
• A Scoping Review on Category A Agents as Bioweapons

  2021cites this paper
• Identification of Novel Antiviral Compounds Targeting Entry of Hantaviruses

  2021cites this paper
• Epidemiological and Ecological Perspectives on Kyas anur Forest Disease-A Review

  2021cites this paper
• Drug‐drug interactions with candidate medications used for COVID‐19 treatment: An overview

  2021cites this paper
• Comparison of the performance of aerosol sampling devices with aerosols containing Ebola virus

  2021cites this paper
• The Electrostatic Features of Dengue Virus Capsid Assembly

  2021cites this paper
• [Evaluation of Efficacy of Ribavirin on Laboratory Test and Severity Score in Crimean-Congo Hemorrhagic Fever in Children].

  2021cites this paper
• Principles of Midwifery Care during Virulent Outbreaks

  2021cites this paper
• Ebolavirus Disease (EVD)

  2021cites this paper
• Immunoinformatics Analysis and In-silico Design of Multi- Epitopes Vaccine Against Lassa Virus

  2021cites this paper
• The COVID-19 - An Agent for Bioterrorism?

  2021cites this paper
• Determining the cellular targets and resulting pathology of rift valley fever virus infection of the rat CNS and reproductive system using microscopy

  2020cites this paper
• Development of Rift valley fever encephalitis in rats is mediated by early infection of olfactory epithelium and neuroinvasion across the cribriform plate

  2020cites this paper
• Viral agents including threat from emerging viral infections

  2020cites this paper
• Hemorrhagic Fevers other than Ebola and Lassa Running title : Viral hemorrhagic fever

  2020cites this paper
• Vaccine Design

  2020cites this paper
• REPTARENAVIRUSES IN CONSTRICTOR SNAKES: TISSUE TROPISM AND IMMUNE RESPONSES

  2020cites this paper
• COVID19 TRANSMISSION OF CORONA VIRUS AND ITS MATHEMATICAL MODEL TO ANALYZE

  2020cites this paper
• Ebola Virus Dose Response Model for Aerosolized Exposures: Insights from Primate Data

  2020cites this paper
• Maintaining neglected tropical disease programmes during pandemics

  2020cites this paper
• Social Science in Humanitarian Action Social Science in Epidemics : Rift Valley Fever Lessons Learned

  2020cites this paper
• Crimean-Congo hemorrhagic fever: etiology, diagnosis, management and potential alternative therapy

  2020cites this paper
• Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors

  2020cites this paper
• Factors affecting hospital response in biological disasters: A qualitative study

  2020cites this paper
• TAM receptors: A phosphatidylserine receptor family and its implications in viral infections.

  2020cites this paper
• Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion

  2019cites this paper
• Lassa fever: Time to eradicate the deadly disease in Nigeria

  2019cites this paper
• Innovative Technologies for Advancement of WHO Risk Group 4 Pathogens Research

  2019cites this paper
• The Ebola virus saga in Nigeria; the view point of a microbiologist

  2019cites this paper
• Pathogenesis of Crimean-Congo Haemorrhagic Fever (CCHF) - interaction of immune response, viral load and clinical course

  2019cites this paper
• Using computational approaches to study dengue virus capsid assembly

  2019cites this paper
• Viral infections of the central nervous system in Africa.

  2019cites this paper
• Metal chelators for the inhibition of the lymphocytic choriomeningitis virus endonuclease domain

  2019cites this paper
• Methods for successful inactivation of Rift Valley fever virus in infected mosquitoes.

  2019cites this paper
• Ebola Virus Disease

  2019cites this paper
• Conglomeration of highly antigenic nucleoproteins to inaugurate a heterosubtypic next generation vaccine candidate against Arenaviridae family

  2019cites this paper
• Virtual Screening and ADME/Tox Study of Inhibitors against Ebola Virus Matrix Protein VP40

  2019influential citation
• Viral Hemorrhagic Fevers Other than Ebola and Lassa.

  2019cites this paper
• Interaction of Ebola Virus with the Innate Immune System

  2019cites this paper
• SAR studies of 4-acyl-1,6-dialkylpiperazin-2-one arenavirus cell entry inhibitors.

  2019cites this paper
• Purpura and Other Hematovascular Disorders

  2019cites this paper
• Anti-Niemann Pick C1 Single-Stranded Oligonucleotides with Locked Nucleic Acids Potently Reduce Ebola Virus Infection In Vitro

  2019cites this paper
• Overview of Human Viral Hemorrhagic Fevers

  2019cites this paper
• Comparison of the Innate Immune Responses to Pathogenic and Nonpathogenic Clade B New World Arenaviruses

  2019cites this paper
• The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors.

  2019cites this paper
• The One Health Approach is Necessary for the Control of Rift Valley Fever Infections in Egypt: A Comprehensive Review

  2019cites this paper
• Dynamic Dystroglycan Complexes Mediate Cell Entry of Lassa Virus

  2019cites this paper
• Host-Pathogen Interactions During Arboviral Infections

  2019cites this paper
• Monocyte-Derived Dendritic Cells as Model to Evaluate Species Tropism of Mosquito-Borne Flaviviruses

  2019cites this paper
• 72 – Vaccines for Healthcare Personnel

  2018cites this paper
• Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs

  2018cites this paper
• A simulation investigation on interaction mechanism between Ebola nucleoprotein and VP35 peptide

  2018cites this paper
• Novel Insights into Cell Entry of Emerging Human Pathogenic Arenaviruses.

  2018cites this paper
• Chapter 28 FUTURE PROSPECTS OF VACCINES AND ANTIBODIES IN BIODEFENSE

  2018cites this paper
• Evaluation of a Needle-Free Vaccine Delivery Device for Vaccinating Rats with Rift Valley Fever Vaccine Candidates

  2018cites this paper
• Chapter 27 MEDICAL COUNTERMEASURES

  2018cites this paper
• Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity.

  2018cites this paper
• Neutralization of Junín virus by single domain antibodies targeted against the nucleoprotein

  2018cites this paper
• Antiviral therapeutic approaches for human rhinovirus infections

  2018cites this paper